SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-050028
Filing Date
2020-09-10
Accepted
2020-09-10 18:05:53
Documents
1
Period of Report
2020-09-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 11657
  Complete submission text file 0001209191-20-050028.txt   13141
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Issuer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KURA ONCOLOGY, INC. 3033 SCIENCE PARK RD, SUITE 220 SAN DIEGO CA 92121
Business Address
WILSON TROY EDWARD (Reporting) CIK: 0001589597 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37620 | Film No.: 201169463